Based on the knowledge of electroconvulsive treatment, the nurse explains to the student nurses that atropine is given before the treatment primarily to:

Appeared in: AIIMS Nagpur NO- 2020

Explanation

Atropine is an anticholinergic medication administered before ECT to reduce the production of oral and respiratory secretions.
ECT involves inducing a brief, controlled seizure under general anesthesia, which impairs the patient's protective gag and cough reflexes.
By drying these secretions, atropine significantly lowers the risk of the patient inhaling saliva or mucus into the lungs (aspiration), which could lead to aspiration pneumonia.
This action is a critical safety measure to ensure the patient's airway remains clear and protected throughout the procedure.

Why Other Options Were Wrong

Option A: Atropine has the opposite effect; as an anticholinergic agent, it blocks muscarinic receptors, which decreases, not increases, body secretions.
Option B: While atropine does reduce gastrointestinal motility, this is a secondary effect and not the primary reason for its use before ECT. The main priority is airway safety.
Option C: Atropine is not an anxiolytic. Medications from the benzodiazepine class (e.g., lorazepam, midazolam) are used to manage pre-procedural anxiety.

Related Visual

No visual required for this question type.

Clinical Relevance

Nursing practice connection: Safe nursing care depends on performing Pharmacological preparation for Electroconvulsive Therapy (ECT) and the role of anticholinergic agents in the correct sequence, documenting the action clearly, and monitoring for the expected response.
The nurse's primary role in ECT premedication is to ensure patient safety by correctly administering drugs like atropine and monitoring for their effects and potential side effects (e.g., tachycardia, dry mouth).
Airway management is a critical component of care during ECT. Reducing secretions is a proactive measure to prevent the life-threatening complication of aspiration pneumonia.
What if? If a patient has a condition like closed-angle glaucoma or significant tachycardia, atropine may be contraindicated. The nurse must report this to the psychiatrist and anesthetist, who may choose an alternative like glycopyrrolate, which has fewer systemic effects.

How to Approach the Question

First, identify the key elements of the question: the procedure (ECT) and the drug (atropine).
Recall the drug class and primary action of atropine. It is an anticholinergic, and a key effect is drying secretions.
Consider the context of ECT. It involves anesthesia and a seizure, which means the patient's airway is vulnerable.
Connect the drug's action to the procedural risk. Drying secretions directly addresses the risk of aspiration when airway reflexes are compromised.
Evaluate the options. 'Prevent aspiration' is a direct safety outcome of reducing secretions. The other options describe either an opposite effect, a secondary effect, or the action of a different drug class.

Concept Tested & Keywords

Concept Tested: Pharmacological preparation for Electroconvulsive Therapy (ECT) and the role of anticholinergic agents.
Stem keywords: electroconvulsive treatment, ECT, atropine, before treatment
Lead-in keywords: primarily to

Question ID

QEBT1uz1zMOrnr4sg1tMaW

Reference Book

E6 Kaplan Sadock's Synopsis of Psychiatry-2022 (pp 1-3768 of 3768) p. 2303-2305

E6 Robert Boland, Marcia L. Verduin - Kaplan and Sadock's Comprehensive Text of Psychiatry-Wolters Kluwer Health (2024) (pp 1-16525 of 16525) p. 11191-11193

Practise the full AIIMS Nagpur NO- 2020

Attempt every question from this paper in a timed mock, then review the full solution for each one.

Attempt this paper Attempt in the NPrep app